Quarterly ResultMay 1, 2026, 11:07 AM
TMO Q1 Revenue +6.2% to $11.0B; EPS $4.43; Net Income +9.6%
AI Summary
Thermo Fisher Scientific Inc. reported strong financial results for the first quarter of 2026, with total revenues increasing 6.2% to $11.01 billion and diluted EPS growing 11.3% to $4.43. The company also saw a significant 9.6% rise in net income attributable to shareholders, reaching $1.65 billion. Operating cash flow improved substantially, and the quarter included $8.87 billion in acquisitions and $3.00 billion in share repurchases, indicating active capital deployment.
Key Highlights
- Acquisitions, net of cash acquired, totaled $8.87 billion for the quarter.
- Total revenues increased 6.2% to $11.01 billion for the three months ended March 28, 2026.
- Net income attributable to Thermo Fisher Scientific Inc. rose 9.6% to $1.65 billion.
- Diluted earnings per share (EPS) grew 11.3% to $4.43.
- Net cash provided by operating activities surged 64.9% to $1.19 billion.
- Purchases of company common stock amounted to $3.00 billion.
- Consumables revenue increased 8.5% to $4.72 billion.
- Life Sciences Solutions revenue grew 12.6% to $2.64 billion.